PPM1D Mutations in Patients with Hematolymphoid Neoplasms

被引：0

作者：

Streich, Lukas ^{[1
]}

Fisher-Campbell, Nora ^{[1
]}

Magallanes-Hoyos, M. Cristina ^{[1
]}

Gandhi, Arpita ^{[1
]}

Li, Peng ^{[2
]}

Wang, Sa ^{[3
]}

Tang, Guilin ^{[3
]}

Wang, Wei ^{[3
]}

Wiszniewska, Joanna ^{[1
]}

Dunlap, Jennifer ^{[1
]}

Raess, Phil ^{[1
]}

Williams, Todd ^{[1
]}

Press, Richard ^{[1
]}

Fan, Guang ^{[1
]}

Xie, Wei ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR USA

[2] Univ Utah, ARUP Labs, Salt Lake City, UT USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1197

引用

页码：S1244 / S1245

页数：2

共 50 条

[1] Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms
Marcellino, Bridget
Tripodi, Joseph
Bar-Natan, Michal
Fruchtman, Harry
Farnoud, Noushin
Lu, Min
Kosiorek, Heidi E.
Dueck, Amylou C.
Rampal, Raajit K.
Mascarenhas, John
Najfeld, Vesna
Hoffman, Ronald
BLOOD, 2019, 134
[2] PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms
Elagooz, Reem
Aly, Mai
Hirsch, Cassandra M.
Przychodzen, Bartlomiej P.
Kuzmanovic, Teodora
Radivoyevitch, Tomas
Visconte, Valeria
Mukherjee, Sudipto
Carraway, Hetty E.
Sekeres, Mikkael A.
Nazha, Aziz
Maciejewski, Jaroslaw P.
Nagata, Yasunobu
BLOOD, 2017, 130
[3] PPM1D mutations are associated with high frequency of fibrotic progression or accelerated phase in myeloproliferative neoplasms
Zhang, X.
He, R.
VIRCHOWS ARCHIV, 2024, 485 : S100 - S101
[4] BIOLOGICAL CHARACTERIZATION OF PPM1D MUTATIONS IN THE CONTEXT OF DIPG
Fons, Nathan
Sundaram, Ranjini
Surovtseva, Yulia
Rusin, Scott
Kettenbach, Arminja
Breuer, Gregory
Bindra, Ranjit
NEURO-ONCOLOGY, 2017, 19 : 12 - 12
[5] PPM1D Truncating Mutations Confer Chemotherapy Resistance in Hematopoietic Stem Cells, Which Is Reversible By PPM1D Inhibition
Kahn, Josephine
Silver, Alexander J.
Mertins, Philipp
Carr, Steven
Jaiswal, Siddhartha
Ebert, Benjamin L.
BLOOD, 2016, 128 (22)
[6] Clinicopathologic Features of Patients with PPM1D Mutations: Myeloid Neoplasm Post Cytotoxic Therapy and De Novo Myeloid Neoplasms
Fisher-Campbell, Nora
Xie, Wei
Streich, Lukas
Magallanes-Hoyos, M. Cristina
Traer, Elie
Li, Peng
Dunlap, Jennifer
Raess, Phil
Williams, Todd
Press, Richard
Fan, Guang
Wang, Sa
Tang, Guilin
Wang, Wei
Swords, Ronan
Gandhi, Arpita
Wiszniewska, Joanna
LABORATORY INVESTIGATION, 2023, 103 (03) : S1134 - S1134
[7] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
S Rayter
R Elliott
J Travers
M G Rowlands
T B Richardson
K Boxall
K Jones
S Linardopoulos
P Workman
W Aherne
C J Lord
A Ashworth
Oncogene, 2008, 27 : 1036 - 1044
[8] A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
Rayter, S.
Elliott, R.
Travers, J.
Rowlands, M. G.
Richardson, T. B.
Boxall, K.
Jones, K.
Linardopoulos, S.
Workman, P.
Aherne, W.
Lord, C. J.
Ashworth, A.
ONCOGENE, 2008, 27 (08) : 1036 - 1044
[9] PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q
Panagiota, Victoria
Meggendorfer, Manja
Shahswar, Rabia
Kandziora, Christian
Klement, Piroska
Schiller, Johannes
Gohring, Gudrun
Kronke, Jan
Haferlach, Claudia
Ganster, Christina
Shirneshan, Katayoon
Gutermuth, Annika
Platzbecker, Uwe
Thiede, Christian
Germing, Ulrich
Schroeder, Thomas
Kobbe, Guido
Klesse, Sabrina
Koenecke, Christian
Schlegelberger, Brigitte
Kroger, Nicolaus
Haase, Detlef
Dohner, Konstanze
Sperr, Wolfgang R.
Valent, Peter
Ganser, Arnold
Thol, Felicitas
Haferlach, Torsten
Heuser, Michael
BLOOD, 2017, 130
[10] Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
Zajkowicz, A.
Butkiewicz, D.
Drosik, A.
Giglok, M.
Suwinski, R.
Rusin, M.
BRITISH JOURNAL OF CANCER, 2015, 112 (06) : 1114 - 1120

← 1 2 3 4 5 →